Dosimetric Impact of Collimator Angle and Arc Number on Target Dosimetry and Organ-at-Risk Sparing in Volumetric Modulated Arc Therapy for Thyroid-Associated Ophthalmopathy
This study demonstrates that in volumetric modulated arc therapy for thyroid-associated ophthalmopathy, a four-arc configuration with a 60°–300° collimator angle offers the optimal balance between target dosimetry and organ-at-risk sparing, while a 75°–285° angle provides the best organ protection, and 0° or 15° angles should generally be avoided.